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Dysarthria is a frequent and persisting sequel to stroke and arises from varied lesion locations. Although the presence of dysarthria is well documented, for stroke there are scant data on presentation and intervention outcome. A literature search was undertaken to evaluate a) the features of dysarthria in adult stroke populations relative to the conventional Mayo system for classification, which was developed from diverse pathological groups, and b) the current status of evidence for the effectiveness of intervention in dysarthria caused by stroke. A narrative review of results is presented.
The limited data available indicate that regardless of stroke location, imprecise articulation and slow speaking rate are consistent features, and voice disturbances, especially harshness, and reduced prosodic variation are also common. Dysarthria is more prevalent in left than in right hemisphere lesions. There is a need for comprehensive, thorough analysis of dysarthria features, involving larger populations, with stroke and other variables controlled and with appropriate age-referenced control data. 




Dysarthria is a neuro-motor disorder which results from abnormalities in speed, strength, steadiness, range, tone, or accuracy of movements required for the control of speech (Duffy, 2005). The speech impairments of dysarthria relate to articulation, phonation, respiration, nasality and prosody, and affect intelligibility, audibility, naturalness, and efficiency of spoken communication. Severity ranges from absence of speech (anarthria) or complete unintelligibility to mild changes which may be evident only to the speaker or by detailed speech evaluation. In contemporary usage dysarthria does not encompass speech disorders which are caused by structural abnormalities, such as cleft palate or glossectomy. It is also distinguished from apraxia of speech, which though of neurological origin, is conceptualised as a disorder of speech motor planning or programming (Duffy, 2005).  Dysarthria is reported to be the most frequently acquired speech and language disorder (Enderby & Emerson, 1995). The significance of stroke as a cause of dysarthria is evident by 22% of a 1276 speech-language pathology (SLP) dysarthria case audit series having stroke aetiology (Duffy, 2005).  

While there has been a fair volume of research into dysarthria in progressive disease and its treatment, notably Parkinson’s disease, dysarthria in stroke tends not to receive specific attention in published texts and reports, despite its frequency. In the SLP literature, dysarthria is normally described with reference to a set of diagnostic categories (the Mayo system, Darley, Aronson & Brown, 1975), within which stroke is combined with other aetiologies. Also there has been little controlled evaluation of any intervention approach in the dysarthric stroke population. No randomised controlled trials have been identified for stroke or other non-progressive dysarthria (Sellars, Hughes & Langhorne, 2005). As with diagnostic descriptions, in treatment studies stroke has often been included with other aetiological groups, such as traumatic brain injury and progressive disorders, and even participants with communication disorders other than dysarthria. 

 Speech-language pathologists (SLPs) who work with adults will often encounter dysarthria in the context of stroke. A synthesis of the literature on the presentation of dysarthria in adult stroke and the current evidence base for intervention is thus relevant. In view of the lack of focus on stroke dysarthia in the SLP literature, some background context is first provided, regarding the prevalence of dysarthria in stroke, variables affecting diagnosis and description, and the course of dysarthria in stroke. 

The prevalence of dysarthria in stroke populations

Dysarthria results from varied stroke lesion locations and its presence may have no localizing value (Kumral & Bayulkem, 2003; Melo, Bogousslavsky, van Melle & Regli, 1992). In prospective studies of large first stroke series, lesions were supratentorial in over 60% of cases (Kumral, Celebisoy, Celebisoy, Canbaz & Calli, 2007; Urban et al., 2006). Infratentorial lesions producing dysarthria were largely pontine and cerebellar. Rarely, and usually associated with lacunar stroke, dysarthria may be an isolated sign (Urban et al., 2006) or present within the dysarthria-clumsy hand syndrome (Arboix et al., 2004). However for the majority of patients, dysarthria occurs in the context of other impairments, and resultant limitations in activity and participation, relating to physical, sensory, psychological and cognitive domains. Dysphagia commonly co-exists with dysarthria, especially where severe (Ropper, 1987). Natural aging or concomitant diseases, including dementia, may further compromise the speech status of the dysarthric stroke population.

Dysarthria in acute first stroke populations is reported as: 53% (Mann, Hankey, & Cameron, 1999) and 41.5% (Lawrence et al., 2001) for general series; 49% for brain stem lesions (Teasell, Foley, Doherty & Finestone, 2002); 48% in middle cerebral artery occlusive disease (Yoo, Shin, Chang & Caplan, 1998); 30% for internal capsule lesions (Fries, Danek, Scheidtmann & Hamburger, 1993); 29% for an isolated hemiparesis group (Melo et al., 1992) and 25% for lacunar infarcts (Arboix, Marti-Vilalta & Garcia, 1990). Examining stroke subsets, Lawrence et al. (2001) found prevalence ranging from 85% in total anterior circulation infarcts to 5% in subarachnoid haemorrhage. 

Variables affecting dysarthria diagnosis and description
Many research design factors may influence the diagnosis and description of dysarthria, relating to participant sample and the nature of assessment. Relevant participant variables include time since stroke, lesion site and extent, exclusion criteria, such as previous stroke, recruitment method, and in smaller series, the extent to which cases are representative of the population. Given the older age group in which stroke most often occurs, suitable comparative speech data from healthy populations should be used in dysarthria diagnosis and description. Amerman and Parnell (1990) reported resemblance between the speech of non-brain-damaged elderly people and those with dysarthria in an auditory-perceptual  speech rating task, with resultant misclassification of normal elderly speakers. Similarly Wang, Kent, Kent, Duffy and Thomas (2009), using instrumental examination, found voice characteristics in a dysarthric stroke series to be similar to those of healthy ageing speakers.
Assessment variables which may affect dysarthria statistics and descriptions include the nature, sensitivity and comprehensiveness of evaluation, and instrument psychometrics, such as reliability and validity. Also important is the experience and acumen of the person who makes the dysarthria diagnosis, in particular whether this is an SLP. Where the full range of dysarthria speech features are not evaluated, description may be incomplete and milder cases may be excluded. Conflicting results may be partly attributable to poor definition of parameters (Urban et al., 2006). Patient and carer evaluations of speech status have been included informally in some investigations of speech features of dysarthria in stroke (Urban et al., 2006). While such reports may not be unbiased and the extent of self awareness will vary, a unique perspective on change, speech difficulties and their effects is available from the individual and people familiar with his/her speech before stroke`.

The course of dysarthria in stroke
Dysarthria has been shown to have some negative effect on level of outcome after stroke (Tilling et al., 2001), but methodical, longitudinal investigation of its natural course has not been undertaken. Urban, Wicht, Hopf, Fleischer and Nickel (1999) recorded dysarthria as clearing within two weeks to six months in all of a group of seven patients who presented with isolated mild-moderate dysarthia subsequent to unilateral lacunar infarct. Ropper (1987) noted that dysarthria, which was initially severe, improved slowly over one to three weeks, in seven of ten patients with right hemisphere stroke, even if other aspects of stroke showed no change. Urban et al. (2006) provide some follow up data on 38 patients with dysarthria following unilateral lesions, a minimum of six months from initial speech examination.  Most speech characteristics were significantly improved. 61% were diagnosed as still having mild dysarthria. Interpretation of these data is however confounded by all patients having received SLP in the first two to four weeks after stroke. Despite such documented improvements, it is evident from the long time after stroke at which assessment has been conducted in some descriptive studies that even unilateral lesions can result in persistent dysarthria. Intervention studies similarly typically report on stroke patients many months or years following onset.

Search questions
To provide a current view of the characteristics of dysarthria in stroke and its management, two questions were addressed by a literature search:
a)	What are the features of dysarthria in adult stroke populations and is presentation consistent with the conventional Mayo system for classification?
b)	What evidence exists for the effectiveness of intervention in dysarthria caused by stroke? 

Search strategy
The search and review of sourced material was carried out by the author. The search was confined to publications in English between 1985 and May 2010 for question a) and between January 2007 and May 2010 for question b). This shorter time period for the latter was selected because of the existence of two comprehensive intervention reviews on non-progressive dysarthria which encompass, but are not confined to stroke (Sellars et al., 2005; Palmer & Enderby, 2007). An initial search was conducted using MEDLINE. To address question a) stroke was used in combination with dysarthria. To address question b) therapy was added as a search term.  MEDLINE applies additional related terms: stroke (apoplexy; apoplexies; cerebral stroke; cerebrovascular accident; cerebrovascular apoplexy; cerebrovascular stroke; strokes; vascular accident brain; cva); dysarthria (dysarthrias; dysarthosis); therapy (therapeutic; management;  treatment; intervention; remedy; relief; amelioration; alleviation). For question a) 30290 references were raised, of which 586 were classified as 5*, having all search terms, or their applied related terms, present and complete. For question b) 5298 references were raised of which 86 were classified as having all search terms present and complete. Abstracts of all 5* references were evaluated to determine their relevance to the questions, according to the following inclusion criteria:
o	Tree (​http:​/​​/​ovidsp.tx.ovid.com​/​sp-3.2.2b​/​ovidweb.cgi?&S=JNHIFPMFKJDDPGCINCDLEBDCJMGDAA00&Subject+Search=1&toolType=tree&textBox=disease%20management​)
1)	data confined to participants with stroke or from which stroke specific data could be clearly distinguished; 
2)	adult population;
3)	dysarthria diagnosis without accompanying apraxia of speech or aphemia and clearly differentiated from any co-existing aphasia.
Additionally for question a):
4)	description of a range of speech parameters derived from specified tasks, including connected speech: data confined to one parameter such as articulation or phonation, or obtained from a single task, such as vowel prolongation or rapid syllable repetition provides a narrow focus without necessarily identifying the dimensions most commonly associated with stroke;
5)	data from a minimum of 10 stroke participants, as the representativeness of single case and small group descriptions cannot be determined. No lower limit as to the number of participants was set for question b) because of the small amount of outcome research.






Question a): Dysarthria presentation in stroke populations
Investigations of the features of dysarthria in large stroke populations are few and methodologically diverse, as regards dysarthria severity, lesions locations and extents, and the point after stroke at which speech assessment was carried out. For the seven discrete studies involving at least 10 participants with dysarthria which were identified, table 1 gives the participant details and table 2 a synthesis of the main dysarthria presenting features. Participant numbers ranged from 10 to 101. In some early studies diagnosis of stroke did not include neuroimaging. Some studies included participants with varied lesion locations and others were restricted to one site, usually upper motor neurone, or cerebellar. Lesions were exclusively unilateral or bilateral in some studies and in other populations both unilateral and bilateral lesions were included. The professional background of the speech assessor is not given in Ropper (1987) and Kumral et al. (2007), but in the latter the detail of measures suggests relevant expertise. In all other studies speech assessment was conducted by experienced SLPs. Time post stroke at which speech assessment took place was highly variable across studies and in some instances within studies. Only two studies (Chenery, Murdoch & Ingram, 1992; Thompson & Murdoch, 1995) included control groups. Where dysarthria severity was noted, this was most commonly mild-moderate. An exception is Ropper’s (1987) right stroke population in whom dysarthria was so severe that much repetition was required for speech to be understood.

table 1 about here

Dysarthria feature descriptions are mainly based on auditory-perceptual ratings of connected speech samples, sometimes supplemented by additional tasks. In several studies a modified neurophonetic test battery (Zeigler, Hartmann, Hoole & Cramon, 1990) was used, including auditory-perceptual ratings of connected speech, syllable, word and sentence repetitions, sustained vowels and fricatives. Comparison of findings across studies is hindered by variations in terminology and descriptive frameworks, the severity threshold applied, and whether control group data were used. In some instances it was not clear whether dimensions were not evaluated or were evaluated but not impaired in the population. However some broad conclusions can be drawn as to the commonly occurring features of dysarthria in stroke:

	Imprecision of articulation, involving consonants, less commonly vowels, and perhaps affecting intelligibility; 
	Slowed speaking rate;
	Monotony of speech, characterised by features such as limited variation in loudness, and less commonly in pitch or stress pattern;
	Voice disturbance, especially harshness, sometimes described as strained-strangled.

Less consistently present are:




table 2 about here
The Mayo system of dysarthria classification
Dysarthria is popularly classified into eight categories: flaccid (lower motor neurone); spastic (bilateral upper motor neurone; ataxic (cerebellum); hypokinetic (basal ganglia control circuit); hyperkinetic (basal ganglia control circuit); unilateral upper motor neurone; mixed (more than one of the foregoing); undetermined (Duffy, 2005). This system of classification, referred to as the Mayo system, predates modern neuroimaging and speech imaging. It originates in auditory-perceptual studies of Darley, Aronson and Brown (1969) in which the presence and extent of 38 speech impairments was evaluated in groups of patients with diagnosed diseases or in whom lesion location was presumed from clinical neurological signs. Some classes, especially spastic, flaccid and ataxic, comprised varying aetiologies, including stroke, and there may have been over-representation of particular lesion groups in some classes (Duffy & Kent, 2001). Arising from this pioneering work of Darley et al. (1969) and subsequent related studies, profiles of speech symptoms are conventionally described for the major dysarthria categories (see table 3 for major distinguishing characteristics). The unilateral upper motor neurone class was not distinguished from spastic dysarthria in the original Darley et al. (1969) classification, but later formally added by Duffy and Folger (1996). According to Duffy’s (2005) clinical audit data, aetiology was vascular in 90% of cases with unilateral upper motor neurone dysarthria, 29% with spastic, 13% with ataxic, 11% with mixed, 9% with hypokinetic, 4% with flaccid and 1% with hyperkinetic dysarthria. Thus stroke is likely to be represented in all categories of the Mayo system.

table 3 about here 

Some common dysarthria features, such as imprecise articulation, are present in all the Mayo dysarthria categories, while there are some features, for example short rushes of speech, which are peculiar to individual categories. Diversity within participant groups with similar lesion locations is evident by apparently contradictory features, for example vocal features indicative of both laryngeal hyperfunction and hypofunction in an upper motor neurone stroke group (Murdoch, Thompson & Stokes, 1991). The existence of subtypes within some categories has been suggested (Duffy & Kent, 2001). Thompson, Murdoch and Theodoros (1997) highlighted the individual variation amongst patients with upper motor neurone strokes, as did Kennedy and Murdoch (1989) in a stroke group with subcortical lesions, whose dysarthria was described as atypical and not consistent with any of the classical categories. Such observations raise questions as to the appropriateness of the Mayo system for stroke cases.

The dysarthria presentation in the seven reviewed stroke studies is broadly consistent with Brookshire’s (2007) summary of discriminatory features (table 3) for spastic and unilateral upper motor neurone dysarthrias. Most of the participants in these studies did have suprabulbar lesions. However similar results were obtained in investigations of, or including, other sites. Urban et al. (2006) found voice impairments, such as harshness and breathiness to be not specifically associated with any lesion site, contrary to conventional association of these features with specific diagnostic categories (spastic, unilateral upper motor neurone, flaccid). The highest levels of dysarthria were found in cerebellar lesions (Urban et al., 2006). Irregular articulatory breakdown is conventionally regarded as a key discriminatory characteristic of ataxic dysarthria, the form associated with cerebellar damage. Urban et al. (2003) noted its presence in a study of a cerebellar lesioned group, but in a larger study of patients with varied lesion sites, the same research group (Urban et al., 2006) observed that irregular articulatory breakdown did not differentiate cerebellar and extra-cerebellar lesions. The cerebellar series (Urban et al., 2003) also failed to reveal scanning speech (excess and equal stress), another feature regarded as typical of cerebellar lesions. Kumral et al. (2007) likewise noted the absence of scanning speech, in a large dysarthria series which included four people with isolated cerebellar leions and a further six who had combined cerebellar and brainstem infarctions. Such findings for stroke conflict with arguments that dysarthria profiles are reflective of different localisations and underlying pathophysiology (Duffy, 2007).

Does dysarthria presentation have localising value?
Dysarthria can be the first indication of neurological disease and its lesion localising value is thought to be valuable, especially where lesions are small and undetected by conventional neuroimaging (Duffy & Folger, 1996). However classification arrived at through auditory-perceptual speech analysis does not necessarily correspond with objective lesion evidence (Wang et al., 2009). Duffy and Folger (1996) noted ataxic-like speech characteristics in patients with unlitaral upper motor neurone lesions and also referred to a practice of designating as flaccid any dysarthria which seemed primarily due to weakness. 

Van der Graaff et al. (2009) comment that statements on dysarthria type are made confidently by neurologists, based on general listening to the patient’s speech. Despite this certainty, neurologists were only 40% correct in identifying dysarthria type in patients with established neurological disease. SLPs were marginally less accurate. Zyszi and Weisger (1987) similarly found experienced dysarthria therapists to be minimally successful in diagnosing dysarthria type or neurological disorder when carrying out auditory-perceptual evaluation of classic cases. The highest level of correct identification was for the hypokinetic class, typically associated with Parkinson’s disease, in which apparently unique features are present, for example rapid rate and short rushes of speech. Although the importance of varied forms of evaluation and data collection is recognised, including movement studies and acoustic analysis, auditory- perceptual analysis is regarded as “the first and most important contributor of clinical diagnosis and measures of functional change in response to management” (Duffy, 2005, p. 14). Assessment of the predictive value of auditory-perceptual analysis for lesion localisation is identified as a key area of dysarthria research (Duffy, 2007). 

Left dominance for speech
Whereas the Mayo approach to dysarthria classification identifies differing speech profiles according to (sometimes presumed) lesion level, there is no consideration of influence of side of lesion. Kumral et al. (2007) and Urban et al. (2006) found dysarthria to be much more common in left than in right supratentorial strokes, suggesting that the descending pathway from the left motor cortex is more dominant. Kumral et al. (2007) noted left side predominance in cerebellar lesions also, but Urban et al. (2006) found the right cerebellum more commonly involved.  However in both studies the number of dysarthric participants with cerebellar lesions was small. 

Dysarthria has also been observed to be more severe in left lesions, irrespective of lesion site (Urban et al., 2006), in respect of articulatory parameters of inaccuracy, vowel and consonant imprecision, phoneme and syllable repetition and elision, and prosodic impairments (slowed and variable speaking rate, phoneme and syllable prolongation and reduced intonation). Benke and Kertesz (1989) in suprabulbar lesion groups, matched for location and volume, also found articulatory errors and rate reduction were more prominent in left than in right lesions, but dysprosody (loss of affective inflection, monotony, equalisation of stress, and lack of emphasis) was more prominent in right lesions. Parameters which were less markedly impaired in stroke patients, specifically voice, hypernasality and intensity control, were not associated with lesion side (Benke & Kertesz, 1989; Urban et al., 2006). 








Varied management and intervention approaches are advocated for dysarthria, via textbooks, therapy resource manuals, research publications and scholarly reviews, but few have been subject to empirical testing. Approaches include behavioural and prosthetic methods targeting speech improvement; maximisation of communication through reduction of dysarthric speakers’ and communication partners’ maladaptive strategies and adoption of positive strategies, including alternative and augmentative communication approaches; education and support for patient and caregivers, including facilitation of adjustment to the changed communication status, with goals such as reduction of the impact of dysarthria, increased confidence in communication and improved quality of communication life. Therapy may be carried out on an individual or group basis, and may involve family members, volunteers and paid assistants, in addition to SLPs and other professionals. In selecting treatment approaches clinicians are guided by various influences, including education and training, discussion with colleagues, observation of others’ practice, reading, the belief that they have relevant evidence from their own practice, patient and carer expectations, and tradition (Mackenzie, Muir & Allen, 2010). Usually a combination of techniques is used, which take account of the type and severity of dysarthria (Palmer & Enderby, 2007). 

Sellars et al. (2005) and Palmer and Enderby (2007) undertook comprehensive evaluation of the therapy outcome literature for non-progressive dysarthria, including but not specific to stroke. The current review is concerned with intervention reports on stroke subsequent to these reviews. First the status of outcome research for stroke at the time of these previous reviews is briefly summarised. 

Sellars et al. (2005) found no SLP studies on non-progressive dysarthria which met the randomised controlled trial criteria for inclusion in a Cochrane systematic review. Palmer and Enderby (2007) identified only 23 SLP treatment reports for stable dysarthria published between 1966 and 2006. Of these ten were clearly, but not solely concerned with stroke.  There were no randomised controlled trials. Most were single cases and the largest stroke participant group was eight. Approaches which reported positive results included modifying speaking rate and prosody using clinician modelling and visual feedback, improving speech clarity through clinical modelling of correct pronunciation, improving loudness, vocal tone and intelligibility using an abdominal binder, biofeedback, and a palatal lift appliance. Further relevant literature informs on improvements in speech intelligibility in structured experimental conditions where listeners were given clues in addition to speech, such as semantic and syntactic context, alphabet, gestural and topic cues (Hanson, Yorkston & Beukelman, 2004). Fukusako et al. (1989) reported on the largest stroke group in dysarthria intervention research to date. This study was not included by Palmer and Enderby (2007) and not being a randomised controlled trial, did not qualify for inclusion in the Sellars et al. (2005) review. The 24 participants were described as having spastic dysarthria, but no further neurological or speech diagnostic information is included. Therapy was individual and methods varied according to needs, such as articulation and non-speech oro-motor practice, rate slowing techniques, and deliberate production.  Auditory-perceptual judgements of speech feature severity indicated 70% had improved. Amongst the design flaws are that pre-intervention stability was not demonstrated and more than 50% of the group began therapy within three months of stroke, at which point spontaneous improvement may have been ongoing. Duration and intensity of therapy varied greatly across the group, and there were indications that more improvement was associated with longer treatment duration. 

The reader is referred to Palmer and Enderby (2007) for further details of studies involving stroke patients between 1966 and 2006. These authors concluded that while the outcome literature for stable dysarthria offers useful management and research pointers, in all cases additional small exploratory trials were necessary in preparation for the randomised controlled trials required to provide evidence of effectiveness. 

Search results 2
Question b) Outcome of intervention: post 2006 studies
Seven early phase trials fulfilling the search criteria and published since the Palmer and Enderby (2007) review were identified (see table 4), but with no existing randomised controlled trials,  the level of evidence for dysarthria intervention in stroke continues to be low and many recommended approaches to intervention remain untested. There have been no investigations with external controls, so Hawthorne effect possibilities (Gillespie, 1991) are not negated.  Although external controls may not be necessary in pilot studies, some measure of internal control may be exercised by assessing pre-intervention stability over time equivalent to the intervention period (Mackenzie & Lowit, 2007), but typically only single point comparisons are provided of pre and post intervention scores. The practice of combining stroke and other neurological aetiologies persists, thus limiting the conclusions which can be drawn from some studies. Only three studies (Mackenzie & Lowit, 2007; Lee & McCann, 2009; Mahler, Ramig & Fox, 2009) were restricted to stroke. Number of stroke participants continues to be small, ranging from one to eight, with time from stroke three to 144 months. Participants received from six -24 sessions, over periods from four weeks to three months, with additional home practice in four studies (Palmer, Enderby & Hawley, 2007; Wenke, Theodoros & Cornwell, 2008; Mahler et al., 2009; Wenke, Theodoros & Cornwell, 2010). Various therapy approaches were used, some individualised, mostly behavioural, targeting a number of speech parameters. Three of the studies used the Lee Silverman Voice Treatment (LSVT) (Ramig, Fox & Sapir, 2004). In six studies treatment was carried out by SLPs and in the remaining study (Tamplin, 2008) by a music therapist. All reported some significant success, in some studies at impairment level and in others encompassing functional measures such as intelligibility, effectiveness, naturalness and wellbeing. Four studies investigated maintenance and in three of these (Mackenzie & Lowit, 2007; Wenke et al., 2008; Mahler et al., 2009) there was evidence of gains being upheld some months after treatment withdrawal. 

table 4 about here

Speech-language pathology interventions
The Lee Silverman Voice Treatment (LSVT) (Ramig et.al., 2004), used in three studies, is a high participant effort program, with a continual focus on increased loudness, which is delivered in four sessions a week for four weeks. LSVT has randomised control trial evidence, supporting its use for the hypokinetic dysarthria in Parkinson’s disease and some lower level, positive results for individuals with dysarthria resulting from cerebellar damage and multiple sclerosis. Wenke et al. (2008) and Wenke et al. (2010) reported on LSVT outcome for three and five stroke patients respectively. In both studies additional participants with traumatic brain injury were included. Wenke et al. (2008) rated outcomes as regards improved vocal loudness, frequency range and intelligibility as similar for stroke and TBI and concluded that LSVT has the potential to be a viable treatment option for dysarthria in stroke, if a respiratory-phonatory component is present. Improvements in speech initation and wellbeing, as reported by participants and partners, were also present. LSVT effects on hypernasality were less convincing, though some improvement was noted immediately after intervention, but not maintained (Wenke et al., 2010). Mahler et al. (2009) reported on the use of LSVT with two stroke participants who had dysarthria plus aphasia. Both participants showed increases in measures of loudness and they and family members considered functional communication to be improved. Listeners rated speech and voice as improved in connected speech for one participant, but not for the other, whose aphasia was the more severe of the two. The authors hypothesised that maintaining loudness may be more difficult where retrieving words is problematical. 

Significant improvements following treatment were reported also by Palmer et al. (2007) for one stroke patient who was included with other pathologies, and for Lee and McCann’s (2009) study of two stroke patients. Using both traditional and computerised delivery treatments Palmer et al. (2007) found single sound production and laryngeal activity to be improved. Lee and McCann found gains in measures of tone production (Mandarin), intelligibility, respiratory and phonatory tasks. Mackenzie and Lowit’s (2007) study concerns the largest number of stroke participants in the post 2006 period. Absence of speech improvement over an eight week non-intervention period was established prior to the eight week intervention. Individual targets were addressed via behavioural methods, with an overall goal of maximisation of comprehensibility and effectiveness. Individual participant analysis indicated statistically significant improvement in five participants in relation to measures of intelligibility and communication effectiveness, with little evidence of deterioration eight weeks following treatment cessation. The three participants who showed no significant gains did not differ in age, dysarthria severity or lesion information from those who improved. 

Interventions involving other professionals
SLPs are the professionals normally responsible for dysarthria intervention. An interesting development builds on applications of music therapy. Based on a single vascular case, Magee, Brumfitt, Freeman and Davidson (2006) tentatively suggested that music therapy techniques might improve some aspects of functional communication and wellbeing in some complex cases where conventional therapy was ineffective. Positive effects of a two and a half month period of vocal exercises and singing on intelligibility and speech naturalness were reported by Tamplin (2008) in a mixed aetiological group which included one stroke participant.

Improvements in speech have been documented previously with the use of intraoral dental appliances which both elevate a weak soft palate, so decreasing nasal emission, and also compensate for decreased tongue elevation (Light, Edelman & Alba, 2001), Ono, Hamamura, Honda and Nokubi (2005) described collaboration between an SLP and a dentist with an individual 29 months after stroke. The dentist provided a palatal prosthesis for severe velopharyngeal incompetence, followed by behavioural treatment from the SLP three times a week for three months, focusing on self-monitoring and biofeedback training for velopharyngeal closure. Intelligibility was reported to improve with the prosthesis, with increased gains following speech treatment.

Considering the above studies and those reviewed by Palmer and Enderby (2007) it may be concluded that in the majority of reported cases there has been some positive response to intervention, with maintenance of gains, where this was evaluated. Positive changes are not limited to impairment measures but often extend to improvements in intelligibility and external and self ratings of overall communication level, where these are included. In comparison with earlier reports there is a general trend towards inclusion of more detailed description of the intervention methods. However the available outcome data are very limited and drawing even preliminary guidance from the results is compromised by the wide variation in amount and type of intervention, and the composition of experimental groups in respect of dysarthria severity, duration and clinical features, and the continuing practice of including stroke with other aetiological groups. 

Conclusions and future intervention research directions
Within SLP the convention is to examine and describe dysarthria with reference to the Mayo diagnostic categories, several of which are derived from individuals with varied neurological diagnoses. Where dysarthria presentation is studied in populations which are restricted to stroke aetiology, the data from this review indicate that there are similarities in the speech characteristics of participants with differing lesion locations. Imprecision of articulation, which may compromise intelligibility, reduction in speaking rate, monotony of speech and harshness are commonly present, regardless of lesion site. There are also indications that dysarthria is more common in left than in right hemisphere lesions, a distinction not embraced by the Mayo system. Dysarthria severity may similarly be influenced by lesion side. However the reliability of much of the existing data is reduced by inconsistencies in methods, lack of clear definition of descriptive terminology, subjectivity and absence of comparative data from non-brain-damaged control participants. Future research might also take account of participant views of speech change subsequent to stroke.

The paucity of research into the outcome of dysarthria therapy in stroke has been highlighted in previous reviews and the situation has changed little since these reviews. It is clear from the current review that some people with stroke demonstrate benefits from interventions, but the small scale of the research, without external controls, does not inform on the generalisability of such results across the dysarthric stroke population. Despite the frequency and persistence of dysarthia in stroke, intervention tends not to be a research priority. Furthermore in recent years there have been considerable increases in dysphagia referrals and consequent reduction in resource allocations for speech and communication disorders in SLP departments (Palmer et al., 2007; Whurr, 2007). Whurr (2007) notes that because few clinics deal with large numbers of patients, a multi-centre approach is necessary for larger scale intervention research. To inform on stroke, aetiology must be restricted to stroke. In view of the differences in incidence and severity in right and left lesions, future research should have more defined stroke inclusion criteria, and control of other potentially relevant variables such as age, cognitive ability and other co-morbidities. Careful description of the interventions used, and control of amounts and durations of input are essential. A study of this type might include a control group who receive only general stimulation, but equivalent in amount of attention to that received by the experimental group. Change must be evaluated in relation to baseline stability and retention of gains after intervention withdrawal should be assessed over many months. 
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Studies of dysarthria in stroke where n >= 10 
Authors (date)	Lesion and diagnostic basis	Time post stroke	Dysarthria group size	Control group	Dysarthria severity 
Ropper (1987) 	Right hemisphere, mixed locations; clinical neurological with CT confirmation in 80% and autopsy in 40% 	Acute	10	none	Severe
Benke & Kertesz (1989) 	UMN unilateral; clinical neurological diagnosis, plus CT confirmation 	Mean 19 days	70	none	Mild-moderate
Chenery, Murdoch & Ingram (1992)	UMN bilateral; clinical neurological diagnosis 	Minimum 6 months	16	16	Not specified
*Thompson & Murdoch (1995) 	UMN unilateral and bilateral; clinical neurological diagnosis, supplemented by CT confirmation in 40%  	4-180 months	20	20	Mild-severe
Urban et al. (2003)	Cerebellar, with and without brain stem involvement, unilateral and bilateral; CT and MRI confirmation 	Within one week	18	none	Mild-moderate
*Urban et al. (2006) 	Mixed locations, unilateral; MRI confirmation	Within 72 hours	62	none	Mild-moderate
Kumral et al. (2007)	Mixed locations uniltateral; diffusion-weighted imaging confirmation	24 hours	101	none	Mild-moderate

* participant data from these studies has been utilised in other publications of the research groups concerned







Dysarthria features in stroke studies (n >= 10)
	Ropper (1987)	Benke & Kertesz (1989)	Chenery et al. (1992)	*Thompson & Murdoch (1995)	Urban et al. (2003)	*Urban et al. (2006)	Kumral et al. (2007)







Reduction in rate/ prolonged intervals/ syllables	+	+	+	+	+	+	+
Monotony/reduced inflection/ emphasis/ reduced pitch/ stress/ loudness variation	+	+	+	+			+
Fluctuation in rate			+				
Repetitions and mouthing of syllables	+						
Phonatory/respiratory impairments							
Harshness/strained-strangled/glottal fry/voice disturbance/pressed voice	+	+	+	+		+	
Reduced phonation length/short phrase length/reduced respiratory support	+		+	+			
Poor loudness/pitch control/fluctuations	+	+		+			
Breathiness/increased soft phonation index						+	
Hypernasality 		+	+				





Traditionally recognised dysarthria classes and distinguishing speech characteristics
 Diagnostic class	Major distinguishing speech characteristics
flaccid 	HypernasalityImprecise consonantsContinuous breathy voiceNasal emissionAudible inspirations
spastic 	Imprecise consonantsStrained-strangled-harsh voiceSlow rate
ataxic 	Inconsistent consonant misarticulationExcess, equal stressIrregular articulatory breakdownIrregular excessive loudness variabilityExcessive rate variability
hypokinetic 	MonopitchReduced stressMonoloudnessBlurring of consonant distinctionsShort rushes of speech
hyperkinetic 	Prolonged intervals between phonemesAbnormal silent intervalsExcess loudness variationProlonged phonemesVariable rate (chorea)Irregular articulatory breakdown (dystonia)Distorted vowels(chorea)
unilateral upper motor neurone	Mild articulatory imprecisionSlow to normal speech rateHarsh-strained voice qualityOccasional hypernasalityOccasional irregular articulatory breakdownDiminished vocal loudness






Stroke dysarthria intervention studies 2007-2010
	Stroke participant number	Time post stroke	Intervention method	Intervention profession	Amount of intervention	Results	Follow-up status
Mackenzie and Lowit (2007)	8	5-82 months	Individualised behavioural and maximisation program, targeting comprehensibility and effectiveness of conversation 	SLP	16 sessions over 8 weeks	Significant improvements in 5 participants , in at least one of 3 measures of reading and word intelligibility and communication effectiveness in conversation 	Little evidence of deterioration at 8 weeks 
Palmer, Enderby and Hawley (2007)	1 + other aetiologies	4 years	Comparison of two individualised programs: traditional and computerised treatment	SLP	6 sessions over 6 weeks +home practice for each program	Significant improvements in single sound production and laryngeal activity, with both methods	Not reported
Tamplin (2008)	1 + other aetiologies	2.5 months	Respiration, rhythmic and melodic intonation exercises, and singing familiar songs	Music therapy	24 sessions over 3 months	Significant Improvements in functional intelligibility and speech naturalness	Not reported
Wenke, Theodoros and Cornwell (2008)	3 + other aetiologies	14-144 months	LSVT	SLP	16 sessions over 4 weeks + home practice	Significantly increased vocal loudness, frequency range and intelligibility; participant and partner reports of improvements in initiation and wellbeing	Most gains maintained at 6 months 
*Lee and McCann (2009)	2	3-12 months	Respiration and phonation therapy	SLP	9 sessions over 3 weeks	Significant Improvements in tone production respiratory and phonatory tasks, and intelligibility in Mandarin. 	Not reported
Mahler, Ramig and Fox (2009)	2	3-4.5 years	LSVT	SLP	16 sessions over 4 weeks + home practice	Significantly increased vocal loudness; self and family reports of improved functional communication; improved listener ratings for speech and voice for one participant	Most gains maintained at 4 months
Wenke, Theodoros and Cornwell (2010)	5 + other aetiologies	12-120 months	Random allocation to LSVT (2) and traditional therapy (3)	SLP	16 sessions over 4 weeks + home practice	Mild reduction in hypernasality for LSVT group	Gains not maintained at 6 months 

LSVT = Lee Silverman Voice Treatment; SLP = Speech-language pathology
*participants were bilingual Mandarin-English. Therapy was conducted in English. 
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